Previous 10 | Next 10 |
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the Cowen Annual Health Care Conference. Cowen Annual Hea...
Sarissa Capital’s board candidates will represent shareholders and help create value at Amarin during this critical period Sarissa Capital believes removing Chairman Per Wold-Olsen from the Amarin board is in shareholders’ best interest Sarissa Capital Management L...
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin’s senior management team to discuss the Company’s fourth quarter and year end 2022 financial resul...
Sarissa believes Amarin leadership will continue to destroy shareholder value during this critical period; We cannot afford to maintain the status quo Sarissa has a stellar track record of success and its nominees have the experience and qualifications to help fix the problems at Amarin ...
Amarin Corp. ( NASDAQ: AMRN ) has told shareholders it should reject a slate of proposals from activist shareholder Sarissa. Amarin ( AMRN ) noted it is at "an inflection point ....Our refreshed Board are the change agents the Company needs and have actively positioned the bus...
The NEW Amarin and NEW Board is On the Right Track – Leading Independent Experts, ISS and Glass Lewis, Agree that Sarissa Representation is Not Warranted Sarissa’s Misguided Campaign to Remove Amarin’s Chairman and Gain De Facto Board Control Would be Detrimental to...
Amarin Deludes Shareholders by Presenting an Alternative Reality Where the Truth Does Not Matter Sarissa Believes that Shareholders Have Suffered Long Enough from the Nightmare under the Current Regime and Should Vote “FOR” Change at Amarin Sarissa Capital Manageme...
Sarissa is Confident that Long Suffering Amarin Shareholders Will Make Up Their Own Minds and Vote “FOR” Change at Amarin Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Saris...
Amarin Corp. ( NASDAQ: AMRN ) shareholders should vote against activist Sarissa's nominees for the board at a vote later this month, proxy advisor ISS recommended. “The board has appropriately refreshed itself and the company's positioning for commercial success appears to be i...
Independent Report Acknowledges That Sarissa’s Campaign to Remove Amarin’s Chairman and De Facto Seize Board Control Would be Detrimental to Shareholder Value Board Urges Shareholders to Follow ISS and Glass Lewis's Recommendations and Vote “AGAINST” Al...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...